Skip to content
10-Q

Quarterly Report

CALYPTE BIOMEDICAL CORP

0001437749-12-008470

← back to feed
Filed
Aug 14, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2012 · Aug 14, 2012 700.17M sh
Shares Diluted Q2 2012 · Jun 30, 2012 700.17M sh
Shares Diluted Q2 2012 · Jun 30, 2012 633.21M sh
Operating Cash Flow Q2 2012 · Jun 30, 2012 −$408K
Cash And Equivalents Q2 2012 · Jun 30, 2012 $8K
Cash And Equivalents Q2 2012 · Dec 31, 2011 $10K
Stockholders Equity Q2 2012 · Jun 30, 2012 −$4.72M
Stockholders Equity Q2 2012 · Dec 31, 2011 −$5.11M
Current Liabilities Q2 2012 · Jun 30, 2012 $2.88M
Current Liabilities Q2 2012 · Dec 31, 2011 $3.41M
Total Liabilities Q2 2012 · Jun 30, 2012 $6.6M
Total Liabilities Q2 2012 · Dec 31, 2011 $7.07M
Current Assets Q2 2012 · Jun 30, 2012 $230K
Current Assets Q2 2012 · Dec 31, 2011 $227K
Total Assets Q2 2012 · Jun 30, 2012 $1.88M
Total Assets Q2 2012 · Dec 31, 2011 $1.96M
Sga Expense Q2 2012 · Jun 30, 2012 $165K
Sga Expense Q2 2012 · Jun 30, 2012 $366K
Rd Expense Q2 2012 · Jun 30, 2012 $68K
Rd Expense Q2 2012 · Jun 30, 2012 $142K
Net Income Q2 2012 · Jun 30, 2012 −$237K
Net Income Q2 2012 · Jun 30, 2012 −$527K
Operating Income Q2 2012 · Jun 30, 2012 −$206K
Operating Income Q2 2012 · Jun 30, 2012 −$463K
Cost Of Revenue Q2 2012 · Jun 30, 2012 $36K
Cost Of Revenue Q2 2012 · Jun 30, 2012 $89K
Stock Issued Q2 2012 · Feb 28, 2011 6M sh
Stock Issued Q2 2012 · Jan 31, 2011 16.67M sh